# Comparative Study of Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of Single Intravenous Doses of BCD-148 and Soliris®

> **NCT04027803** · PHASE1 · COMPLETED · sponsor: **Biocad** · enrollment: 78 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **BIOLOGICAL:** BCD-148
- **BIOLOGICAL:** Soliris

## Key facts

- **NCT ID:** NCT04027803
- **Lead sponsor:** Biocad
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-21
- **Primary completion:** 2019-04-07
- **Final completion:** 2019-04-07
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2020-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04027803

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04027803, "Comparative Study of Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of Single Intravenous Doses of BCD-148 and Soliris®". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04027803. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*